A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease

• Published in: Molecular biology reports Vol. 48; no. 4; pp. 3785 - 3798
• Main Authors: Li, Jiashan, Wang, Chao, Liu, Jiaru, Yu, Ying, Liu, Yuee, Peng, Qi, Liu, Huihui, Guan, Xiuru
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.04.2021; Springer Nature B.V
• Subjects: Animal Anatomy; Animal Biochemistry; Animals; Biomedical and Life Sciences; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - blood; Cardiovascular Diseases - genetics; Cardiovascular Diseases - metabolism; Clonal Hematopoiesis; Cytokines - genetics; Cytokines - metabolism; Feedback; Hematopoietic stem cells; Histology; Humans; Inflammation; Janus kinase 2; Life Sciences; Morphology; Mutation; Older people; Positive selection; Review; Risk factors; Stem cell transplantation; Stem cells; Somatic cell mutation; Aging; Cardiovascular disease; Inflammation; Hematopoietic stem cells; Clonal hematopoiesis
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-021-06370-5

Age and inflammation are powerful drivers of cardiovascular disease. With the growing recognition that traditional cardiovascular risk factors are not fully accurate predictors of cardiovascular disease, recent studies have revealed the prevalence of positive selection of somatic cell mutations in hematopoietic stem cells in the elderly population, which can cause clonal hematopoiesis. Interestingly, clonal hematopoiesis is not only associated with cancer and death, but also closely related to the risk of increased cardiovascular disease due to mutations in TET2, DNMT3A, ASXL1, and JAK2. However, the mechanism of the interaction of clonal hematopoiesis and cardiovascular disease is only partially understood. In mice, somatic mutations have led to significantly increased expression of inflammatory genes in innate immune cells, which may explain the relationship between mutations and cardiovascular disease. Here, we further discuss the association between inflammatory signaling, clonal hematopoiesis, and cardiovascular disease,and using two hypotheses to propose a feedback loop between inflammatory signaling and clonal hematopoiesis for getting insight into the pathogenesis of cardiovascular diseases in depth. Therapies targeting mutant clones or increased inflammatory mediators may be useful for ameliorating the risk of cardiovascular disease.